This safeguards patient health while allowing personalized adjustments
Compounded tirzepatide is a non-FDA-approved preparation prepared by a state-licensed compounding pharmacy under an individual prescription from a licensed US provider
The combination of these factorsdelayed gastric emptying, potential aerophagia, and normal digestive processes occurring in a stomach with altered motilityexplains why burping is recognised as a gastrointestinal side effect during treatment with tirzepatide, particularly during the initial weeks of therapy or following dose escalation
please consult a licensed healthcare provider to determine any details as related to GLP-1 for your health
Lie MRKL, van der Giessen J, Fuhler GM, de Lima A, Peppelenbosch MP, van der Ent C, van der Woude CJ